Enlight Biosciences, advancing discovery technologies, signs up new partners AstraZeneca and Novo Nordisk
This article was originally published in Scrip
Executive Summary
AstraZeneca and Novo Nordisk have joined a number of other big pharmaceutical companies that are supporting Boston-based Enlight Biosciences, a three-year-old start-up with a goal of developing technologies to improve drug discovery. The goal has been to address critical unmet industry needs.